JEH.F genOway Société anonyme

Healthcare Biotechnology Frankfurt Exchange
1.85 EUR
Close of Nov 13, 2026
1.70 2.70
Market cap
EUR 22.8M
P/E
-
P/B
0.99x
ROE
3.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is JEH.F undervalued?

Graham number

The Graham number of genOway Société anonyme cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

genOway Société anonyme fundamental analysis

No fundamental analysis for genOway Société anonyme yet.

genOway Société anonyme stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About genOway Société anonyme

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick K…

Full company profile